Clinical Trial Update: Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial examines glucagon-like peptide receptor expression in the stomach of individuals with type 2 diabetes; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: UNKNOWN